Monoclonal antibody 175 recognizes a cell-surface antigen on more than 80% of nucleated ovine bone marrow cells (BMC). The distribution is unusual, as the majority of differentiated myeloid and erythroid cells express the antigen (175 antigen), whereas mast cells, basophils, and the majority of lymphocytes do not. The level of 175 antigen expression has been shown to increase as BMC differentiate during hematopoiesis. Previous attempts to identify the 175 antigen have been unsuccessful. In this study, the 175 antigen was affinity-purified and shown to contain serine protease activity. lmmunoblot analysis following sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) of bone marrow cell lysates run under reducing or nonreducing conditions HE MONOCLONAL antibody (MoAb) 175 was obtained from mice immunized with ovine leukocytes and reacts with between 80% and 90% of nucleated adult ovine bone marrow cells (BMC)."4 The distribution of the 175 antigen is unusual, as it is expressed on the majority of myeloid and stromal cell lineages in bone marrow and all morphologically recognizable stages of erythroid development, but is absent on basophils, mast cells, and bone marrow Expression is absent on precursors of hematopoietic progenitor colony-forming cells (CFC) in vitro, but increases on the majority of myeloid and erythroid cells as they develop into mature cells via CFC during hemat o p~i e s i s .~.~ In the periphery, blood and tissue neutrophils, monocytes/macrophages, and eosinophils, as well as tissue fibroblasts and some stromal cells, express high levels of the 175
(IO to 20 mL) were applied to the affinity column equilibrated with PBS, and the eluant monitored for protein content at OD 280 nm. Bound material was eluted by the addition of 0.5 mol/L of NaCl in 0.1 m o w of citric acid, pH 4.5, and neutralized by the addition of 2 m o m Tris, pH 1 I , then concentrated at least IO-fold in a Centricon 10 microconcentrator cell (Amicon, Stonehouse, UK) at 6 , 0 0 0~ for 3 hours.
The isolate was analyzed by immunoblotting after separation on a S%, 12% discontinuous sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel run under reducing conditions at 200 V for I hour.' Electrotransfer was performed in a semidry system onto nitrocellulose membranes (Bio Bond-NC; Whatman, Maidstone, UK) as described by Khyse-Anderson,' and was achieved in I hour with a current of 2 mA/cm2 of gel. The transferred proteins were incubated with IO pg/mL of 175 MoAb for 1 hour at 22°C followed by I O pg/ml of sheep antimouse IgM (prepared in this laboratory) conjugated with horse-radish peroxidase (Boehringer Mannheim, Lewes, UK) as described by Wilson and Nakane.9 A duplicate track was probed with I O pg/mL of an IgM fraction of an anti-border disease virus (BDV) MAb-VPM12 as a control. Bound MoAb was visualized using the enhanced chemiluminescence (ECL) reagent (Amersham International, Little Chalfont, UK) according to the manufacturer's instructions and blots exposed to Hyperfilm MP (Amersham) for 1 to 5 minutes before development.
N Radioiodination of cell-surJace proreins. BMC surface proteins were radiolabeled with 1"' using the lactoperoxidase method of Marchalonis." Briefly, 8 X IO6 freshly isolated BMC were resuspended in 0.5 mL of PBS containing 0.1 U of lactoperoxidase (Boehringer Mannheim) and 500 pCi of camer-free NaltZ5 (Amersham). The reaction was initiated by the addition of 2 pL of 0.001 5% freshly diluted H2OZ. Three further additions of HZO2 were made every minute before the reaction was terminated by the addition of PBS containing I mmol/L of dithiothreitol and 5 mmol/L of tyrosine (Sigma). The cells were then washed extensively in PBS and split into two aliquots to which was added 500 pL of PBS containing 2% bovine serum albumin (BSA) and 0.05% sodium azide, then either 5 pg of 175 MoAb or 5 pg of the IgM fraction of VPM12 for 40 minutes on ice. Cells were then washed twice in PBS and lysed as described previously in 1 mL of lysis buffer. Aliquots of 1 0 0 pL (containing -15 pCi of radiolabeled product) of each lysate were added in quadruplicate to wells of an 96-well enzyme-linked immunosorbent assay plate (Dynatech Laboratories, Billinghurst, UK) coated with 1 p@mL of sheep antimouse IgM antibody. Nonspecific binding of protein was blocked by washing the plates with 3% BSA in PBS. After washing the wells extensively, bound complex was removed by the addition of 1 0 0 pL of SDS-PAGE sample buffer. Pooled material was concentrated IO-fold in concentrator cells and analyzed by SDS-PAGE on a 4%,10% discontinuous gel system run under reducing conditions as described previously.
Inhibition ofprotease activity by specific protease inhibitors. Affinity-purified 28-kD 175 antigen in 30-pg aliquots was incubated with the following previously optimized concentrations of specific protease inhibitors in 0.1 mL of 25-mmoVL Tris-buffered saline at pH 8. Mannheim; inhibits thiolproteases), I mmol/L 1.10-phenanthroline (Sigma; inhibits metalloproteases), and 50 pmolL pepstatin A (Sigma; inhibits acid proteases). To each mixture was then added an equal volume of SDS-PAGE sample buffer without 2-mercaptoethanol and without boiling, and samples were run on 4%,10% gels as described earlier but with 0.2% (wt/vol) azocasein (Sigma) in the separating gel component. Once run, substrate gels were washed in 2 v01 of 2.5% Triton X 1 0 0 in water for 2 hours, then briefly in water and finally in PBS before an overnight incubation at 37°C. Digestion of the substrate was detected by staining the gel with Coomassie brilliant blue and identifying clear areas.
Inhihition of protease activity by 175 MoAb. Affinity-purified I75 antigen was separated on substrate gels containing azocasein as described, along with either a I-m@mL gel of 175 MoAb or VPM12
MoAb. In adjacent tracks, 20-to 50-pg samples of the proteases trypsin, chymotrypsin (Sigma), and elastase (Boehringer Mannheim) were also run.
RESULTS
Analysis of afJinity-purifed antigen. From Western blot analysis of total BMC lysates, it was difficult to define unequivocally any particular protein bands as specifically immunoreactive with the 175 MoAb. However, fractionation of the lysate by 175 MoAb affinity chromatography showed a closely associated protein doublet band within the range of 28 to 30 kD that reacted with the 175 MoAb on subsequent imrnunoblot analysis run under either reducing or nonreducing conditions (Fig 1) . The immunoreactivity of the upper 30-kD band was considerably reduced, whereas that of the lower 28-kD band was enhanced by digestion of the sample before separation with the endoglycosidase PNGase-F (Fig  2) . The 175 antigen will therefore be referred to as a 28-kD glycoprotein.
For In some analyses, a 17-kD band was also observed (Fig  l) . A 20-amino acid N-terminal sequence analysis showed homology to the a-chain of hemoglobin. This bound nonspecifically to 175 MoAb and a selection of other IgM and IgG control murine MoAbs (Fig 3) .
N-terminal sequence analysis. Increased resolution of the protein doublet band was achieved by running gels of greater length and at a higher acrylamide concentration (12%). Following analysis, both the 28-and 30-kD bands were found to have the same N-terminal amino acid sequence over 20 residues. This sequence was compared with those filed with the NBFR PIRI-3 Protein Sequence Library. The search showed complete homology over 20 amino acids at the N-terminus between 175, 28-kD antigen and that of a serine protease of bovine origin ( Table l ) . The 175, 28-kD antigen also exhibited N-terminal amino acid sequence homology to several other serine proteases, including a human leukocyte cationic antimicrobial heparin-binding protein (azurocidin) and elastase-like proteins of pig and human origin ( Table 1) .
Cell-surJace expression of the 28-kD protein.
To demonstrate that the 28-kD protein isolated from BMC lysates corresponded to the cell-surface antigen immunoreactive with the 175 MoAb in flow-cytometric analysis of viable BMC; radiolabeled BMC surface proteins were analyzed after immunoprecipitation (Fig 3) . In addition to the expected 28-kD component, a less intense band of approximately 55 kD was also detected. The 17-kD hemoglobin chain also bound nonspecifically to the 175 MoAb and to a lesser extent the control IgM MoAb (Fig 3) .
Protease activiht of the 28-kD protein. The affinity-purified 28-kD protein was associated with protease activity as shown in azocasein substrate gels (Fig 4) . Furthermore activity was inhibited only by the serine protease inhibitor PMSF and not the metallo, thiol, or acid protease-specific inhibitors. The 28-kD antigen proteolytic activity was also inhibited by inclusion of the 175 MoAb in the substrate gel (Fig 5) . Inhibition of protease activity in the 28-to 30-kD range in total BMC lysates was only partially blocked when compared with the affinity-purified material. The activities of a selection of other serine proteases in the substrate gels were not inhibited by the 175 MoAb. 
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The 175 antigen shared an identical N-terminal 20-amino acid sequence to a serine protease that coprecipitated along with basic fibroblast growth factor from bovine pituitary cells immunoreactive with an antibody to basic fibroblast growth factor." The 175 MoAb reacts with a population of cells that line the sinuses of ovine pituitary (unpublished data), but initial attempts to isolate a complex of 175 antigen with lower-molecular weight proteins on heparin-sepharose, as described in the bovine," have been unsuccessful.
Serine proteases are ubiquitous enzymes with multiple activities on cell and tissue development and f~nction.".'~ and cell-surface proteases may play a role in cell differentiation, migration, and control of inflammation.'X~''' The 175 protease has a different cellular distribution to other reported proteases on hematopoietic cells.'" High levels of expression are seen on bone marrow or tissue monocytes and macrophages, neutrophils, eosinophils, stromal and fibroblast cells, and bone marrow erythroid series cells.'"' However, expression of 175 antigen is absent (or below detectable levels) on mast cells, basophils, and the majority of lymphocytes. Expression of 175 antigen increases on hematopoietic progenitor cells as they develop from precursors of CFC (undetectable level) via more lineage-restricted CFC to differentiated BMC.)'s The 175 antibody has therefore proven useful in a cocktail of antibodies used to deplete more mature BMC, leaving a highly enriched population of early clonogenic CFC' and their precursors.s
The significance of the distribution of the 175 antigen and the initiation of functional studies must await the cloning of the cDNA, which is currently underway. In addition, it will be of interest to identify whether there is an equivalent human antigen. 
DISCUSSION
The characterization of a cell-surface antigen expressed on more than 80% of ovine myeloid and erythroid cells is described. MAb antibody 175 recognizes a BMC surface protein with the activity and N-terminal amino acid sequence of a serine protease. The antigen runs as a protein doublet of between 28 and 30 kD when analyzed by SDS-PAGE under reducing or nonreducing conditions. The 30-kD component is a glycosylated form of the 28-kD protein. The cellsurface nature of this antigen had been previously demonstrated by immunofluorescent studies on isolated cells'.' and confirmed by the lactoperoxidase-radiolabeling experiment described in this study. The antigen has also been detected by immunocytochemistry within the cytoplasm of cells (unpublished data). The serine protease activity of the affinitypurified 175 antigen was confirmed in substrate gels being inhibited by the serine protease-specific inhibitor PMSF, but not by inhibitors of thiol, metallo, or acid proteases. The 175 MoAb specifically blocked proteolytic activity of the affinity-purified antigen and also. to a lesser extent. activity in the 28-to 30-kD range in BMC lysates. The inability of 175 MoAb to block completely protease activity in the BMC lysates is probably due to a clustering of different proteases in and around this molecular weight range in SDS-PAGE gels. among which are at least three diisopropylfluorophosphate (DFP) binding serine proteases (unpublished). 
